Business

Better Home & Finance Holding Company Reports $1.64B in Preliminary Funded Loan Volume for Q1 2026, Exceeding Prior Guidance; Strengthens Balance Sheet and Announces Strategic Actions to Drive Profitable Growth

Summary of Announcements: Q1 2026 preliminary Funded Loan Volume of $1.64B, exceeding pri...

articleBetterlife Pharma Inc.April 8, 20265/company/betterlife-pharma-inc/news/better-home-and-finance-holding-company-reports-dollar164b-in-preliminary-funded-loan-volume-for-q1-2026-exceeding-prior-guidance-strengthens-balance-sheet-and-announces-strategic-actions-to-drive-profitable-growth
Better Home & Finance Holding Company Reports $1.64B in Preliminary Funded Loan Volume for Q1 2026, Exceeding Prior Guidance; Strengthens Balance Sheet and Announces Strategic Actions to Drive Profitable Growth

About this update from Betterlife Pharma Inc.

[{"type":"text","content":"Better Home & Finance Holding Company Reports $1.64B in Preliminary Funded Loan Volume for Q1 2026, Exceeding Prior Guidance; Strengthens Balance Sheet and Announces Strategic Actions to Drive Profitable Growth\n\n\n .bwlistdisc { list-style-type: disc }\n \n\n\n\n\n Summary of Announcements:\n \n\n\n\n Q1 2026 preliminary Funded Loan Volume of $1.64B, exceeding prior guidance of $1.40B to $1.55B\n \n\n Oversubscribed Public Offering of $60M of Class A common stock with over-allotments of up to $9M for an anticipated total of $69M; terminating the At-The-Market (ATM) program\n \n\n $25M of annualized cost reductions beginning Q2 2026\n \n\n U.K.-based bank: classified as held for sale effective Q1 2026; active sale process underway\n \n\n\n\n\n Better Home & Finance Holding Company (NASDAQ: BETR; BETRW) (“Better,” the “Company,” “our” or “we”), the AI-native mortgage and home equity finance company, today reported $1.64B in preliminary funded loan volume for Q1 2026 exceeding prior guidance; strengthens balance sheet and announces strategic actions to drive profitable growth.\n \n\n This press release features multimedia. View the full release here:\n \n https://www.businesswire.com/news/home/20260408319615/en/\n \n\n\n\n\n\n “I am pleased to report that our Q1 2026 Funded Loan Volume of $1.64 billion exceeded our guidance and increased by 89% year-over-year. March Funded Loan Volume reached $671 million, reflecting accelerating momentum despite the quarter being seasonally softer for purchase volumes. Our decision to raise capital, simplify our international footprint, and reduce costs will position the Company to act decisively on high-conviction growth opportunities without reliance on the equity capital markets for the foreseeable future,” said Vishal Garg, Chief Executive Officer.\n \n\n\n Capital Raise; Termination of ATM:\n \n\n The Company announced a Public Offering of Class A Common Stock of $60M (the “Offering”) with over-allotments of up to $9M totaling an anticipated total of $69M before underwriting discounts and commissions. The Offering price reflects an approximate 3.9% discount to the Company’s 30-day volume weighted average price of the Company’s Class A common stock as of 4/7/26. After closing, the Company wi...

More updates from Betterlife Pharma Inc.